Bioprinting for more predictive efficacy and safety testing

In December 2015 the NC3Rs, NAT SIG, Innovate UK and the Knowledge Transfer Network jointly hosted a workshop to advance the development and application of bioprinting approaches for improved efficacy and safety testing of drugs and other chemicals.

The workshop was organised as part of the Non-Animal Technologies programme to accelerate the uptake of novel technologies that have the potential to transform business and improve product development across a range of industries. Bringing together scientists from across sectors and disciplines the meeting:

  • Highlighted capabilities and opportunities in bioprinting in the UK;
  • Highlighted end-user needs and potential applications for bioprinting;
  • Connected potential end-users with bioprinting technology developers to encourage collaboration in model development;
  • Defineed opportunities for future NATs funding.

Programme

The workshop consisted of presentations, posters and networking opportunities. Speakers from academia and industry covered current capabilities in bioprinting approaches, gaps and opportunities for development, and potential new applications in a range of industries. 

The workshop agenda can be accessed here.

Output

The workshop produced a number of key recommendations for supporting the bioprinting community in the development of new tissue models for adoption by a range of industries for improved safety and efficacy testing. These are currently being collated in a report for publication and will be showcased here when it is available.

Presentations and posters from the workshop will also soon be available on this page.

Do you have questions about the NATs programme?  Do you want to contribute news, events or funding information to this community?

Contact the NAT team

Upcoming NATs events

There are no results.